News

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
It is the second time in a year that a U.S. court has found Google to have illegally maintained a monopoly. A judge in ...
From ‘Ozempic face’ to ‘Ozempic fingers’ and even ‘Wegovy butt,’ the potential side effects of weight loss medications have ...
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
Imagine a world where managing type 2 diabetes doesn't involve needles. A new experimental pill might just change the game, ...
You'll be happy to know Eli Lilly has created a GLP-1 agonist in pill form, and it may be just as effective at lowering blood ...
As The New York Times explains, peptides are small fragments of proteins ... How does orforglipron compare to drugs like ...
The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like Ozempic.
Pharmaceutical company Eli Lilly’s study of its tablet, orforglipron, has raised hopes of an effective and easy-to-use ...